Patent application number | Description | Published |
20140007235 | Identification of Infected Devices in Broadband Environments | 01-02-2014 |
20140331308 | Combination of Remote Triggered Source and Destination Blackhole Filtering - A method for remote triggered black hole filtering can include advertising a first modified next hop address for a destination address of network traffic, and advertising a second modified next hop address for a source address of network traffic. The first next hop address of the destination address might be overwritten with the first modified next hop address. Filtered traffic then can be forwarded to the first modified next hop address, wherein filtered traffic comprises only network traffic addressed to the destination address or from the source address. In some cases, the filtered traffic is transported and received via a sinkhole tunnel. A second next hop address of the source address can be overwritten to a second modified next hop address. The attack traffic, which can be filtered traffic that is both addressed to the destination address and from the source address, might be forwarded to a discard interface. | 11-06-2014 |
20150195298 | Identification of Infected Devices in Broadband Environments - Novel solutions for detecting and/or treating malware on a subscriber's premise network. Such solutions can include, but are not limited to, tools and techniques that can detect, and/or enable the detection of, malware infections on individual subscriber devices within the subscriber's network. In a particular embodiment, for example, a premise gateway, or other device on the subscriber's premise network, is configured to analyze packets traveling through the premise gateway and, based on that analysis, identify one or more subscriber devices that are infected with malware. | 07-09-2015 |
Patent application number | Description | Published |
20150126595 | TRANSDERMAL CANNABINOID FORMULATIONS - The present invention includes a transdermal composition which contains a pharmaceutically effective amount of a cannabinoid for delivery of the cannabinoid to the bloodstream of a user. The composition may comprise the following components: a surfactant-lecithin organogel; and a cannabinoid. The composition may also comprise an exogenous terpene. The cannabinoid is capable of diffusing from the composition into the bloodstream of the user, and may be used in methods for treating a patient suffering from a condition such as pain, nausea and emesis, convulsions, muscle spasm, inflammation, depression, and cachexia. | 05-07-2015 |
20150297556 | TRANSDERMAL CANNABINOID PATCH - The present invention includes a transdermal patch which contains a pharmaceutically effective amount of a cannabinoid for delivery of the cannabinoid to the bloodstream of a user. The patch may comprise the following components: a backing; and a skin-adhesive polymer matrix attached to one side of the backing, which includes a cannabinoid, a carrier agent, a terpene, and a permeation agent. The cannabinoid is capable of diffusing from the matrix in the transdermal patch into the bloodstream of the user, and may be used in methods for treating a patient suffering from a condition such as pain, nausea and emesis, convulsions, muscle spasm, inflammation, depression, and cachexia. | 10-22-2015 |
20160022627 | TRANSDERMAL CANNABINOID PATCH - The present invention includes a transdermal patch which contains a pharmaceutically effective amount of a cannabinoid for delivery of the cannabinoid to the bloodstream of a user. The patch may comprise the following components: a backing; and a skin-adhesive polymer matrix attached to one side of the backing, which includes a cannabinoid, a carrier agent, a terpene, and a permeation agent. The cannabinoid is capable of diffusing from the matrix in the transdermal patch into the bloodstream of the user, and may be used in methods for treating a patient suffering from a condition such as pain, nausea and emesis, convulsions, muscle spasm, inflammation, depression, and cachexia. | 01-28-2016 |